Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma
Authors:
Open Access
- 28 July 2023
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 80 (8) , 1-16
Abstract
Microenvironmental factors are known fundamental regulators of the phenotype and aggressiveness of glioblastoma (GBM), the most lethal brain tumor, characterized by fast progression and marked resistance to treatments. In this context, the extracellular matrix (ECM) is known to heavily influence the behavior of cancer cells from several origins, contributing to stem cell niches, influencing tumor invasiveness and response to chemotherapy, mediating survival signaling cascades, and modulating inflammatory cell recruitment. Here, we show that collagen VI (COL6), an ECM protein widely expressed in both normal and pathological tissues, has a distinctive distribution within the GBM mass, strongly correlated with the most aggressive and phenotypically immature cells. Our data demonstrate that COL6 sustains the stem-like properties of GBM cells and supports the maintenance of an aggressive transcriptional program promoting cancer cell proliferation and survival. In particular, we identified a specific subset of COL6-transcriptionally co-regulated genes, required for the response of cells to replicative stress and DNA damage, supporting the concept that COL6 is an essential stimulus for the activation of GBM cell response and resistance to chemotherapy, through the ATM/ATR axis. Altogether, these findings indicate that COL6 plays a pivotal role in GBM tumor biology, exerting a pleiotropic action across different GBM hallmarks, including phenotypic identity and gene transcription, as well as response to treatments, thus providing valuable information for the understanding of the complex microenvironmental cues underlying GBM malignancy.Keywords
Funding Information
- Istituto di Ricerca Pediatrica - Città della Speranza (IRP18/06)
- Fondazione Cassa di Risparmio di Padova e Rovigo (17/07_1 FCR, 20/16 FCR, 15-2016)
- Ministero dell’Istruzione, dell’Università e della Ricerca (2015FBNB5Y, 201742SBXA)
- Università degli Studi di Padova (STARS Grants programme, PRID-DMM)
- Fondazione Umberto Veronesi (#2601, #3628, #4420, #4820)
- Università degli Studi di Padova
This publication has 86 references indexed in Scilit:
- Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumoursEMBO Molecular Medicine, 2013
- NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansionJournal of Molecular Cell Biology, 2013
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expressionCell Death & Disease, 2012
- The extracellular matrix: A dynamic niche in cancer progressionJournal of Cell Biology, 2012
- Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancerSurgery, 2011
- Expression of the Collagen VI α5 and α6 Chains in Normal Human Skin and in Skin of Patients with Collagen VI-Related MyopathiesJournal of Investigative Dermatology, 2011
- Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouseDevelopmental Biology, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001